[DPHARMA] YoY Annualized Quarter Result on 30-Sep-2015 [#3]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
24-Nov-2015
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2015
Quarter
30-Sep-2015 [#3]
Profit Trend
QoQ- 5.46%
YoY- -4.62%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 CAGR
Revenue 510,784 474,312 318,542 241,705 167,916 155,561 133,242 25.08%
PBT 56,010 51,961 33,573 42,968 43,452 41,356 35,064 8.11%
Tax -11,648 -11,518 -9,580 -11,714 -10,685 -9,122 -8,374 5.65%
NP 44,362 40,442 23,993 31,253 32,766 32,233 26,689 8.83%
-
NP to SH 44,362 40,829 25,156 31,253 32,766 32,233 26,689 8.83%
-
Tax Rate 20.80% 22.17% 28.53% 27.26% 24.59% 22.06% 23.88% -
Total Cost 466,421 433,869 294,549 210,452 135,149 123,328 106,553 27.88%
-
Net Worth 501,487 474,230 451,913 268,509 187,436 179,125 167,965 19.98%
Dividend
30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 CAGR
Div 13,197 - - - 7,404 - - -
Div Payout % 29.75% - - - 22.60% - - -
Equity
30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 CAGR
Net Worth 501,487 474,230 451,913 268,509 187,436 179,125 167,965 19.98%
NOSH 661,881 278,959 278,959 278,959 138,841 138,856 138,814 29.71%
Ratio Analysis
30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 CAGR
NP Margin 8.69% 8.53% 7.53% 12.93% 19.51% 20.72% 20.03% -
ROE 8.85% 8.61% 5.57% 11.64% 17.48% 17.99% 15.89% -
Per Share
30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 CAGR
RPS 77.41 170.03 114.19 144.93 120.94 112.03 95.99 -3.52%
EPS 6.79 14.49 8.60 18.72 23.60 23.21 19.23 -15.92%
DPS 2.00 0.00 0.00 0.00 5.33 0.00 0.00 -
NAPS 0.76 1.70 1.62 1.61 1.35 1.29 1.21 -7.45%
Adjusted Per Share Value based on latest NOSH - 278,959
30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 CAGR
RPS 53.06 49.27 33.09 25.11 17.44 16.16 13.84 25.09%
EPS 4.61 4.24 2.61 3.25 3.40 3.35 2.77 8.85%
DPS 1.37 0.00 0.00 0.00 0.77 0.00 0.00 -
NAPS 0.5209 0.4926 0.4694 0.2789 0.1947 0.1861 0.1745 19.98%
Price Multiplier on Financial Quarter End Date
30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 CAGR
Date 28/09/18 29/09/17 30/09/16 30/09/15 30/09/14 30/09/13 28/09/12 -
Price 1.23 2.20 2.06 2.72 3.17 2.55 2.36 -
P/RPS 1.59 1.29 1.80 1.88 2.62 2.28 2.46 -7.01%
P/EPS 18.30 15.03 22.84 14.51 13.43 10.99 12.27 6.88%
EY 5.47 6.65 4.38 6.89 7.44 9.10 8.15 -6.42%
DY 1.63 0.00 0.00 0.00 1.68 0.00 0.00 -
P/NAPS 1.62 1.29 1.27 1.69 2.35 1.98 1.95 -3.04%
Price Multiplier on Announcement Date
30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 CAGR
Date 28/11/18 17/11/17 21/11/16 24/11/15 21/11/14 19/11/13 23/11/12 -
Price 1.07 2.20 2.10 2.70 3.01 2.56 2.28 -
P/RPS 1.38 1.29 1.84 1.86 2.49 2.29 2.38 -8.67%
P/EPS 15.92 15.03 23.29 14.41 12.75 11.03 11.86 5.02%
EY 6.28 6.65 4.29 6.94 7.84 9.07 8.43 -4.78%
DY 1.87 0.00 0.00 0.00 1.77 0.00 0.00 -
P/NAPS 1.41 1.29 1.30 1.68 2.23 1.98 1.88 -4.67%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment